SEEKING THE ACADEMIC TITLE OF “PROFESSOR”
According to the Rules for awarding academic titles (associate professor, professor) approved by the Order of the Minister of Education and Science of the Republic of Kazakhstan dated March 31,…
Research institute for biological safety problems
According to the Rules for awarding academic titles (associate professor, professor) approved by the Order of the Minister of Education and Science of the Republic of Kazakhstan dated March 31,…
According to the Rules for awarding academic titles (associate professor, professor) approved by the Order of the Minister of Education and Science of the Republic of Kazakhstan dated March 31,…
On October 28, 2020, the President of the Republic of Kazakhstan Kassym-Zhomart Tokayev accepted the General Director of the Research Institute for Biological Safety Problems Kunsulu Zakarya. Kassym-Jomart Tokayev heard…
On October 16, 2020, the Minister of Education and Science of the Republic of Kazakhstan Aimagambetov Askhat Kanatovich paid a working visit to the National Scientific Center for Phthisiopulmonology of…
On October 16, 2020, the Vice Minister of Education and Science of the Republic of Kazakhstan Daulenov Miras Mukhtarovich paid a working visit to RIBSP. According to the Program of…
Clinical trials of the QazCovid-in vaccine against coronavirus infection developed at the Research Institute of Biological Safety Problems of the Committee of Science MES RK have begun. The Ministry of…
On September 16, 2020, a round table was held at the Institute to discuss the Message of the President of the Republic of Kazakhstan Kassym-Jomart Tokayev “Kazakhstan in a new…
The Research Institute for Biological Safety Problems of the Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan (RIBSP) is recruiting volunteers who will take…
The World Health Organization (WHO) has officially included our domestic inactivated vaccine, developed by scientists of our Institute, into the list of vaccines approved for clinical trials. Kazakhstan vaccine with…
Preclinical studies of the Kazakhstan inactivated COVID-19 vaccine developed by the Research Institute for Biological Safety Problems (RIBSP) of SC MES RK on the basis of the pharmacological testing laboratory…